Cheat Sheet

DIC (Disseminated Intravascular Coagulation)

Triggers, clot-then-bleed physiology, labs and the ISTH score, blood products, heparin and nursing care

Reviewed by Alex G, BSN, RN, CEN, CCRN, CMC, NREMT-P · Checked against current sources November 2026

Practice 6 DIC (Disseminated Intravascular Coagulation) questions free

Page 1 of the DIC (Disseminated Intravascular Coagulation) PDF, a printed page in columns with sections on What DIC is, Triggers, Signs, Labs and the ISTH overt DIC score, Treatment, Nursing priorities, DIC or a look-alike? and Exam pearlsEnlarge

One-page PDFLetter landscape, ready to print or keep with your notes

View PDFDownload

DIC (Disseminated Intravascular Coagulation): one-page PDF preview

Page 1 of the DIC (Disseminated Intravascular Coagulation) PDF, a printed page in columns with sections on What DIC is, Triggers, Signs, Labs and the ISTH overt DIC score, Treatment, Nursing priorities, DIC or a look-alike? and Exam pearls

View PDFDownload

What DIC is

DIC is always caused by another illness. Tissue factor released by infection, injury, cancer or the placenta switches on clotting throughout the body. Tiny clots block small vessels and injure organs, and the clotting uses up platelets and clotting factors faster than the body can replace them, so the client then bleeds.

Triggers

GroupExamples
InfectionSepsis, the most common cause (DIC in 30–50% of severe sepsis)
ObstetricPlacental abruption, amniotic fluid embolism, HELLP, eclampsia, fetal death
CancerAcute promyelocytic leukemia (APL); adenocarcinoma (pancreas, stomach, lung, prostate)
Tissue injuryMajor trauma, head injury, burns, surgery, shock
OtherHemolytic transfusion reaction, snakebite, pancreatitis, aortic aneurysm

About 1 in 5 clients with HELLP syndrome develop DIC. In abruption or fetal death, DIC can clear within hours once the uterus is emptied.

Signs

Labs and the ISTH overt DIC score

TestIn DIC
PlateletsLow or falling
PT/INR and aPTTProlonged
FibrinogenLow or falling (may stay normal in sepsis)
D-dimer, fibrin degradation productsHigh (sensitive, not specific)
Blood smearSchistocytes (fragmented RBCs)
Score only when a cause of DIC is present. 5 or more is compatible with overt DIC. ISTH 2025 sets D-dimer over 3× normal at 2 points, over 7× at 3.
ISTH itemPoints
PlateletsOver 100,000: 0; 50,000–100,000: 1; under 50,000: 2
D-dimerNormal: 0; moderate rise: 2; strong rise: 3
PT prolonged byUnder 3 s: 0; 3–6 s: 1; over 6 s: 2
Fibrinogen100 mg/dL or more: 0; under 100: 1

Treatment

Nursing priorities

DIC or a look-alike?

ConditionCluesKey difference
DICTrigger present; bleeding and clotsLong PT/aPTT, low fibrinogen, high D-dimer
TTPSchistocytes, low platelets, confusionNormal clotting tests; ADAMTS13 under 10%: plasma exchange
HUSSchistocytes, low platelets, kidney failureNormal clotting tests; more kidney failure, less confusion than TTP
HITPlatelets fall over 50% on heparin; new clotsClotting, rarely bleeding: stop ALL heparin, even flushes
Liver diseaseLong PT/INR, low plateletsFactor VIII normal or high (low in DIC); lower D-dimer

Exam pearls

Practice DIC (Disseminated Intravascular Coagulation) questions free in your browser6 exam-style questions with rationales. No account or download needed.

In depth

The one-page summary above is what the PDF prints. These sections go further.

Pathophysiology in more detail

Tissue factor from damaged endothelium, monocytes in sepsis, tumor cells or placental tissue activates factor VII and the extrinsic pathway, making thrombin and fibrin. Natural anticoagulants (antithrombin, the protein C system) are consumed or suppressed, and in sepsis plasminogen activator inhibitor-1 rises and blocks fibrinolysis, so clots persist in small vessels and organs fail. Where fibrinolysis is strong, plasmin breaks fibrin into D-dimer and other degradation products, which themselves impair platelets and add to bleeding. RBCs forced through fibrin strands fragment into schistocytes.

Type (ISTH 2025)Typical causesPicture
Thrombotic (fibrinolysis suppressed)SepsisOrgan failure, modest bleeding; fibrinogen often normal
Hemorrhagic (fibrinolysis enhanced)APL and other blood cancers, amniotic fluid embolism, transfusion reactionsOozing and hemorrhage; very low fibrinogen, very high D-dimer

The ISTH 2025 definition also stages DIC as pre-DIC, early and overt, so that treatment can start before the overt score is reached.

Sepsis-induced coagulopathy (SIC) score

4 or more is sepsis-induced coagulopathy, the early phase that can progress to overt DIC.
Item1 point2 points
Platelets100,000–149,000Under 100,000
PT ratio (INR)Over 1.2 to 1.4Over 1.4
SOFA (respiratory, cardiovascular, liver, kidney)12 or more

Replacement and anticoagulation: the evidence

Platelets and plasma have never been shown to fuel DIC, but no high-quality trial guides thresholds. ISTH 2013 and the British guideline (2009) reserve products for bleeding, high bleeding risk or procedures. Fibrinogen under 1 g/L (100 mg/dL) that persists after plasma is treated with fibrinogen concentrate or cryoprecipitate. Prothrombin complex concentrate replaces only some factors and is not a routine choice (Merck cites thrombosis risk).

Heparin: prophylactic UFH or LMWH for critically ill clients who are not bleeding; therapeutic doses where thrombosis predominates or in slow DIC with venous or arterial clots. Merck notes one exception in bleeding DIC: a retained dead fetus with steadily falling platelets and fibrinogen, where heparin is given for several days before the uterus is evacuated. Antithrombin, activated protein C (withdrawn) and recombinant thrombomodulin have not improved survival in large trials.

Practice free in your browser4,850+ exam-style questions with rationales. Free today, no account, no ads. Pro is coming in January 2027. Also free on the App Store and Google Play.

Related cheat sheets

Calculators for this topic

Sources

  1. Costello RA, Leslie SW, Nehring SM. Disseminated Intravascular Coagulation. StatPearls. Treasure Island (FL): StatPearls Publishing; updated May 1, 2024. Link
  2. Merck Manual Professional Version. Disseminated Intravascular Coagulation (DIC). Full review Jul 2025. Link
  3. Papageorgiou C, Jourdi G, Adjambri E, et al. Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies. Clin Appl Thromb Hemost. 2018;24(9 suppl):8S-28S. Link
  4. Wada H, Thachil J, Di Nisio M, et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines (ISTH SSC on DIC). J Thromb Haemost. 2013;11(4):761-767. Link
  5. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol. 2009;145(1):24-33. Link
  6. Iba T, Maier CL, Scarlatescu E, Levy JH. The ISTH 2025 definition and diagnostic criteria of disseminated intravascular coagulation. Semin Thromb Hemost. 2026;52(1):10-17. Link
  7. Iba T, Levy JH, Raj A, Warkentin TE. Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation. J Clin Med. 2019;8(5):728. Link
  8. Merck Manual Professional Version. Acute Myeloid Leukemia (AML). Full review Feb 2026. Link
  9. Merck Manual Professional Version. Thrombotic Thrombocytopenic Purpura (TTP). Full review Jun 2026. Link
  10. Merck Manual Professional Version. Thrombocytopenia: Other Causes (heparin-induced thrombocytopenia). Link
  11. Open Resources for Nursing (Open RN). Health Alterations, 3.10 Thrombocytopenia: bleeding precautions. Link